Tedros Adan Ghebreyesus Photo: DENIS BALIBOUSE / Reuters
Production of anti-inflammatory drug dexamethasone, which the world health organization (who) called a breakthrough in the treatment of coronavirus, should be increased, said who Director-General Dr tedros adhanom Ghebreyesus. His words leads RIA Novosti.
Of ghebreyesus said that the drug demonstrated its effectiveness. “Although the data are still preliminary, recent studies showing that the steroid drug dexamethasone has the potential to save the lives of critically ill patients with COVID-19, give us a reason to celebrate,” he said.
The CEO of the organization also noted the need to distribute the drug worldwide “with a focus on those places where it is most needed”.
Earlier, Director General of the world health organization (who) tedros adhanom Ghebreyesus has announced the scientific breakthrough in the treatment COVID-19 with dexamethasone. He referred to clinical trials scientists from Oxford. According to their findings, the drug reduces the risk of death of infected that are connected to the ventilator or are on oxygen treatment.
However, later the Director of the Institute of pulmonology at the hospital Assuta Daniel Starobin stated that the dexamethasone can cause harm to the health of the patient in the treatment of mild forms of the coronavirus, or the prevention of disease.
Video, photo All from Russia.